Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.
about
SLE - Practical and theoretical barriers to the prevention of accelerated atherosclerosis in systemic lupus erythematosusCurrent and emerging treatment options in the management of lupusDo neutrophil extracellular traps contribute to the heightened risk of thrombosis in inflammatory diseases?Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studiesHigh-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting MechanismsAccelerated atherosclerosis in patients with SLE--mechanisms and managementCardiovascular comorbidity in rheumatic diseases: a focus on heart failureSystematic review of the quality of prognosis studies in systemic lupus erythematosusUnmet medical needs in systemic lupus erythematosusCardiorheumatology: cardiac involvement in systemic rheumatic diseaseCardiovascular disease in lupus: insights and updatesThe Sphinx's riddle: cardiovascular involvement in autoimmune rheumatic diseaseTherapy insight: systemic lupus erythematosus as a risk factor for cardiovascular diseaseLong-term frequent use of non-steroidal anti-inflammatory drugs might protect patients with ankylosing spondylitis from cardiovascular diseases: a nationwide case-control studyThe endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeabilityPharmacological undertreatment of coronary risk factors in patients with psoriasis: observational study of the Danish nationwide registriesNon-invasive imaging of vascular inflammation.The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.Cardiovascular Disease in Women: Clinical Perspectives.Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort.Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort.Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort.Factors associated with coronary artery calcification in young female patients with SLE.Vascular responsiveness in the microcirculation of patients with systemic lupus erythematosus is not impaired.Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosusMetabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients.Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus.Risk of stroke in patients with rheumatism: a nationwide longitudinal population-based study.Rheumatic autoimmune diseases in women and midlife healthManagement of cardiovascular complications in systemic lupus erythematosus.Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.Factors associated with arterial vascular events in PROFILE: a Multiethnic Lupus Cohort.Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus.Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosusRisk factors in the progression of subclinical atherosclerosis in women with systemic lupus erythematosus.Apolipoprotein-containing lipoprotein subclasses and subclinical atherosclerosis in systemic lupus erythematosus.
P2860
Q24804985-CC824BE3-0734-4750-9CA6-B756DCBC03B4Q26741266-FF737188-7000-465E-8867-C8F247ABA70EQ26771128-3DF6BC51-8075-489E-AA73-1725FAD03FDBQ26771476-96808D34-B6DA-4770-9A0D-5DAD3A694525Q26774658-6BB51611-8CCA-4CED-B822-7059ADE81443Q26820245-77D8C9E7-CBE7-47F9-B154-3F964B1FA3D8Q26823443-597503E3-A79A-41CE-BE31-B0842AB217DBQ26823668-59B4BC12-2949-4232-99CF-02FD5ED5DC69Q27005906-85BBB324-D539-489D-B090-24E9FDF1D55BQ27008927-B5B80653-CA2D-482D-AA43-57A66036E050Q27016554-5AE1BFAD-AA33-4126-85F2-8AE9B7F3CC8FQ28069667-89414695-8B4A-4000-A6DC-010664596845Q28188901-A9BA63C8-04C7-430D-9660-3F4A3DAB1AB9Q28547208-ED96D2E5-C1DA-435C-AE20-31F372268A96Q28649846-322C944C-8281-479D-BAEF-8A35FB9B8CF2Q28730205-04315D44-FFC1-4736-903A-F941C53B3186Q30431621-F2CAAC38-125B-4588-BF0B-4287B81CF390Q30497355-FFD5F364-151F-4642-A5D9-5B6933680464Q30560952-C2903E2D-CEDA-4523-85AA-3C65F74633B9Q30743765-259C9166-221F-41EC-9D6D-74C67BEAF258Q30791606-8F751069-C1F9-4F86-A11E-07EC0FAF6A7AQ30823425-35B5C5DF-BADD-4431-BEAC-B0FCAE544CC7Q31122937-4119D38F-1E52-445F-A31B-E0B934EE4B46Q33188178-EDD6A621-9BCF-4754-99EF-CBED87F243AEQ33375575-D2A37643-189A-444A-9C0F-C42351FB308AQ33387473-013C99E6-1603-49D7-B152-417C7A2797D4Q33389669-E03B9515-EAD2-4B8A-A106-2B2853518864Q33425745-EC7CDB67-8C37-4382-AA1A-F2C7C61163E6Q33448450-86B58E73-EFAF-48A9-8769-67D6CF80241CQ33570432-2B9CD17D-1A11-40BC-9F3B-F192DACF3A19Q33659103-4B83993D-0441-47D3-A941-46C23BC05D4CQ33714074-E6FB8657-CA39-49B5-88C7-17BC15C7494BQ33727015-40D29C41-E2DA-4521-A88E-28A71F1E250EQ33730536-07BEAF64-B9BB-4D6A-BD34-EAE3D10E095BQ33748970-C489BED5-9B34-4394-ACE3-981B4B811896Q33758208-162154F5-DEAA-4DEC-9C5E-37ED15E49C67Q33784693-ED16A856-63D4-4DB0-BEE8-40DAD24EAB6AQ33799781-90FECD1E-2EF8-4CC9-A03C-C561F48C8C57Q33800900-E3AB8343-3554-4080-9A7E-81C36F762563Q33887814-E1B159F1-759A-4170-9476-72F54755F5A3
P2860
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Traditional Framingham risk fa ...... systemic lupus erythematosus.
@ast
Traditional Framingham risk fa ...... systemic lupus erythematosus.
@en
Traditional Framingham risk fa ...... systemic lupus erythematosus.
@nl
type
label
Traditional Framingham risk fa ...... systemic lupus erythematosus.
@ast
Traditional Framingham risk fa ...... systemic lupus erythematosus.
@en
Traditional Framingham risk fa ...... systemic lupus erythematosus.
@nl
prefLabel
Traditional Framingham risk fa ...... systemic lupus erythematosus.
@ast
Traditional Framingham risk fa ...... systemic lupus erythematosus.
@en
Traditional Framingham risk fa ...... systemic lupus erythematosus.
@nl
P2093
P1476
Traditional Framingham risk fa ...... systemic lupus erythematosus.
@en
P2093
Esdaile JM
Grodzicky T
Panaritis C
Senécal JL
du Berger R
P304
P356
10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I
P577
2001-10-01T00:00:00Z